Trial intelligence / Profile preview

Pregabalin in idiopathic restless legs syndrome

2005-002130-35Phase 3Active

Sponsor
Instituto de Estudios del Sistema Nervioso
Start
Jun 2005
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in restless legs syndrome (RLS) comparing Pregabalin with Placebo (2 arms). Primary endpoint: International Restless Legs Study Group Rating Scale. Started Jun 2005; status: active.

02

Drugs

pregabalin
03

Conditions

restless legs syndrome (RLS)

Beyond the preview

Go deeper on 2005-002130-35.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2005-002130-35.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call